Social Media Ideas for Emerging Therapies

Four Ways Health Systems Should Plan for the Next Wave of Breakthrough Therapies

Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, they create major clinical, operational and financial...

Proposing the Synergy of Therapeutic Plasma Exchange and Partial Epigenetic Reprogramming

It seems a little early in the development of partial epigenetic reprogramming as a class of therapy to be thinking about which of the other approaches to aging it can best be comb...

<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]>

Gene and Disease-Modifying Therapies for Hemophilia

Inside the evolving hemophilia treatment landscape, including AAV-based gene therapies, non-factor prophylaxis, and approaches that aim to reduce treatment burden. The post Gene an...

<![CDATA[How New Therapies are Tackling Unmet Needs in IBS]]>

Regenerative Medicine Innovations Shaping The Future Of Healthcare

Healthcare looks different today than it did a decade ago. Patients now expect treatments that support recovery, reduce long-term complications, and improve quality of life. Resear...

Six TIL therapy companies to watch out for 

The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the clinic. The post Six TIL therapy companies to watch out for...

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Advanced Therapies Bring New Hope to Blood Cancer Patients in India

Mumbai (Maharashtra) [India], September 2: A blood cancer diagnosis is abrupt and overwhelming. When families hear terms like Acute Myeloid Leukemia or Hodgkin Lymphoma, finding ge...

From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance

The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next generation of cancer treatments. We spoke with Andrea Wang-Gil...

As Food Allergy Treatments Become Big Business, Pharma Bets on VT-7208

Pharma is betting big on an experimental oral drug targeting BTK that is advancing toward Phase 2 trials for food allergy, chronic hives, and multiple sclerosis. The post As Food A...

Cellogen Therapeutics is developing CAR-T cell therapies for blood cancers in India

The Delhi company designs and manufactures its own cell and gene therapies and is preparing a first clinical trial with Christian Medical College, Vellore.

Compact genetic switch offers new potential therapies for drug-resistant epilepsy

Targeted gene therapy is increasingly viewed as a promising route for patients with drug-resistant epilepsy, a condition that affects roughly one-third of people living with epilep...

<![CDATA[What if patient onboarding evolved alongside today's therapies?]]>

Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy

One analyst views Roivant’s pulmonary hypertension drug as a future $10 billion-plus seller. Elsewhere, AstraZeneca overcame a negative advisory committee vote and Pharvaris claime...

Considering Replacement Based Therapies to Treat Aging

How far can one go, practically speaking, and in the relatively near future, to develop therapies to treat aging based on replacement of worn parts? Some forms of replacement thera...

In vivo CAR T Industry Leaps Forward with Challenges Ahead

The emerging new class of in vivo CAR T therapeutics is seen by regulators as gene therapies with risks of off-target effects to patients. Manufacturers need to rise to the challen...

PTC takes a chance on Sangamo’s Fabry disease gene therapy

Wall Street analysts view the deal as a risky, high-reward bet on a treatment that’s nearing a possible regulatory approval and could be superior to existing medications.

How New Science is Reshaping Ovarian Cancer Treatment and Care

Ovarian cancer is often diagnosed at an advanced stage, but research is reshaping how scientists understand and treat the disease. From discoveries about its origins to new FDA-app...

Why payers should have these 3 pipeline drugs on their radar

Optum Rx's latest look at the drug development pipeline highlights three drugs for rare and chronic conditions that payers and plan sponsors should be watching.

Race for approval: biotechs accelerate bipolar disorder therapies 

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects. The post Race for approval: biotechs accelerate bipolar disorder the...

How AOCs are advancing targeted therapeutics

The concept of targeted therapeutics is often traced back to German Nobel laureate Paul Ehrlich’s “magic bullet” in 1907, which envisioned a single entity that could both recognize...

Novel Epigenetic Therapy Targets Treatment-Resistant and TP53-Mutant AML

The results of a preclinical study across multiple models of acute myeloid leukemia found that the investigational hypomethylating agent, NTX-301 remained effective in treatment-re...

The State of Stem Cell Therapies

First generation stem cell therapies that use a variety of cell sources and protocols are widely used in the medical tourism industry. A more limited set of such therapies are used...